Homocysteine (HCY) has been identified as a risk factor for vascular disease in the general population. Diabetic retinopathy (DR) itself rather than hyperhomocysteinemia is the leading cause of blindness among patients with type 2 diabetes mellitus (T2DM). Our study was conducted with 60 healthy control subjects and 178 subjects with T2DM. They were enrolled in the Diabetes Prevention Program from September 2007 to December 2008. Of the 178 patients, 121 cases (68%) had DR Mean plasma total HCY (tHCY) levels were found to be higher in T2DM patients compared to controls (p <0.001), and were also higher than that of the DR group (p <0.001). Plasma folic acid levels were lower in the DR group compared with T2DM without DR and the control group (p <0.001), but there were no significant differences between the latter and the controls. Moderate hyperhomocysteinemia was significantly associated with lower vitamin B12 and folic acid concentrations and older age. Concentrations of serum total cholesterol, LDL-cholesterol (LDL-C), and triglycerides (TG) were significantly raised (p <0.001) whereas the level of HDL-cholesterol (HDL-C) was decreased (p <0.001) in diabetic subjects as compared to controls. Logistic regression analysis showed that DR after adjustment was significantly associated with the following factors: cholesterol, HDL-C and TG. The analysis in DR patients after controlling for cholesterol and TG was independent of plasma tHCY concentrations (OR = 28.5 and OR = 11.9; respectively). In conclusion, results suggest a possible association between moderate hyperhomocysteinemia, traditional risk factors and folic acid deficiency could be an independent risk factor for DR.
Introduction
The incidence of diabetes mellitus (DM) and its complications are increasing rapidly due to an aging population and the Westernization of life styles (1, 2) . Diabetic retinopathy (DR) is one of the most sightthreatening complications of DM and one of the most important emerging causes of blindness (3) . It accounts for about 2.4 million cases of blindness globally (4) . A proportion of 4.8% of the global population suffers from DR (5), while 3 (5) to 4.1% (6) of Europeans are affected.
DR is the leading cause of blindness among patients with type 2 diabetes mellitus (T2DM) (7) . About one third of all cases of impaired visual function in patients with T2DM is due to retinopathy, the remainder to glaucoma, macular degeneration and other causes. Blindness has been estimated to be 25-times more common in persons with DM than in those without (8) .
After having suffered 20 years from T2DM, more than 60% of the patients have some degree of retinopathy (7) . Diabetic retinopathy occurs in 70% of all persons having diabetes for more than 15 years (9) , while the prevalence of DR varies between 20% to 60% in different studies (10) . Although the prevalence of DR increases with the duration of diabetes, studies have shown that intensive glycemic control can delay its development (11) . Still the pathogenetic mechanisms of DR are incompletely understood. DR seems to be a retinal vascular disorder, probably beginning in the capillary bed. Epidemiological studies have shown that the risk and severity of DR are strongly related to the duration of DM, hyperglycemia, hypertension, and also, but less consistently, to hypercholesterolemia and smoking (7) .
Homocysteine (HCY) is a sulfur-containing amino acid derived from methionine metabolism as an intermediate metabolite. Clinically, the normal concentrations of total plasma HCY (tHCY) ranges between 5 and 15 µM. In recent years, moderate hyperhomocysteinemia (HHCY) has been implicated in systematic hypertension, stroke, and other cardiovascular disease (12) . In the ocular system, many lines of evidence indicated HHCY as a risk indicator of retinal arteriosclerosis (13) . Notably, most retinopathies associated with HHCY are indirectly caused by retinal arteriosclerosis and thrombosis (14) .
Patients with tHCY concentrations >15 µM are classified as HHCY and the conditions are commonly associated with DM (15) . Several studies have reported that tHCY is linked to vaso-occlusive disorders in the eye (16) (17) (18) and may represent a useful biomarker or a novel risk factor for increased risk of DR in patients with T2DM (19) (20) (21) (22) . Some studies, however, do not support this conclusion (23, 24) Low concentrations of B vitamins are associated with increased risk of vascular damage possibly through HCY, including vaso-occlusive diseases of the eye. Vitamins supplementation for the management of T2DM has been reported (25) , but its role in the prevention and development of T2DM in general and diabetic complication is not clear.
T2DM is a major public health problem around the world, and it could become a major threat to health in the future. No data are available about the mean levels of tHCY in Algerian diabetic patients with DR. Thus, the aim of the present study is to investigate the prevalence of moderate HHCY in two groups of diabetic patients with and without DR, and compared to a control group.
Materials and Methods

Study design and subjects
This study hospital-based case-control study consists of 178 T2DM patients (91 women and 87 men; (gender ratio: 1.04 : 1) either with or without retinopathy (DR, n = 121 and no DR, n = 57, respectively) were enrolled in the Diabetes Prevention Program from September 2007 to December 2008. In addition, we recruited 60 control subjects (30 men and 30 women; gender ratio: 1 : 1) consisting of friends, partners and employees of the Sétif University Hospital. The control group consisted of asymptomatic subjects aged >40 years without any history of cardiovascular disease and renal complications. Controls were matched with the study group patients regarding potential confounding factors such as sex, systemic hypertension, diabetes mellitus, and smoking states.
Subjects with T2DM with and without DR were recruited from patients attending the Internal Medicine Section and were matched for duration of diabetes. Diabetes was diagnosed according to the World Health Organization Criteria. All patients who participated in the study were treated with oral hypoglycemic drugs (metformin, gliclazide) (75.4%), subcutaneous insulin injections (14.9%) or a combination of both (9.7%). No person in the healthy group was administrated any vitamin supplementation or drugs influencing tHCY and lipid metabolism. Hypertension was defined as a systolic blood pressure >130 mmHg, a diastolic blood pressure >90 mmHg or use of antihypertensive medication. A current smoker was determined as a subject who smoked at least ten cigarettes/day at the time of completing the questionnaire. Patients with macroangiopathy, proteinuria >300 mg/24h, pregnancy and type 1 diabetes were excluded from this study. Retinopathy was assessed by ophthalmoscopy and fundus photography. Thereafter, two 45°standard field, 35-mm black-and-white fundus photographs were taken of each eye. Photographs were taken with a green filter, centered on the macular area and the optic disc.
DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines as follows: non-proliferative diabetic retinopathy if microaneurysms, capillary obstruction and distention, cotton wool spots, hard exudates was present and proliferative diabetic retinopathy with neovascularization of retina or iris, scars, vitreous hemorrhage, retinal detachment or glaucoma was present.
Written informed consent was obtained from all the participants, and the study was approved by the Local Ethics Committee of Sétif University Hospital. All patients were living in the same geographic area of Northern Algeria (Sétif).
Biological sample collection
Blood samples were collected from controls and patients admitted to Sétif University Hospital (Algeria) after an overnight fast. Venous blood was obtained by puncture of median cubital vein, collected in EDTA tubes and immediately put on ice and centrifuged within 1h at 3000 rpm for 10 min at 4°C. The plasma fraction was aliquoted and stored at −20°C to await analy-sis of tHCY and other of biochemical analysis.
Biochemical analysis
The concentration of tHCY, folic acid and vitamin B12 were determined using a competitive immunoassay on the IMMULITE and IMMULITE 1000 Analyzers (Siemens Medical Solutions Diagnostics, Los Angeles, CA, California) using reagents and calibrators. Assays were conducted according to the manufacturer's instruction using IMMULITE 1000 analyser. Total cholesterol, triglycerides (TG), glucose and creatinine concentrations were measured in heparinized plasma in the 2h following sampling by the colorimetric method (Beckman CX9 autoanalyser (USA) with Beckman Kits). Glycosylated hemoglobin (HbA1c), HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), and microalbuminury concentration were measured by the colorimetric method (COBAS INTE-GRA 400, Mannheim, Germany). Assays were conducted according to the manufacturer's instructions.
Statistical analysis
Statistical analysis was performed using SPSS for Windows version 10.0. Mean and SD values of tHCY, age, duration of disease, and other of biochemical parameters were calculated. We compared risk factors between case and control subjects using ANOVA test. The relationship between tHCY, vitamin B12, folic acid, age, duration, TG, cholsterol, HDL-C and LDL-C was calculated by Spearman rank correlation coefficients, and the risk was estimated by odds ratio with logistic regression model. The adjusted odds ratio was calculated as an estimate of the relative risk of DR for individuals with HHCY and other parameters. The ? analyses of each categorical variable were combined by Cochran-Mantel-Haenzel (CMH) pooling of odds ratio (ORs) and corrected for multiple hypothesis testing. Logistic regression was performed with adjustment for other DR risk factors. Statistical significance was accepted at p <0.05.
Results
This is a hospital-based case-control study consisting of T2D subjects with and without DR along with healthy controls. The characteristics of the controls and patients groups are shown in Table 1 . As expected, the mean of age was higher in the DR group than in no-DR group (p <0.001), and a further increase was found in the controls compared with the DR group (p <0.001) ( Table 1) .
Fasting HHCY was considered as the mean of the plasma tHCY for controls ± 2 SD (9.97 ± 2 x 2.57; 15.11 µM in total group). The mean plasma tHCY level was higher in the DR group compared with the no-DR group (p <0.01), and a further increase (p <0.001) was found in the control group compared with the DR group, but no significant difference was found between the no-DR group and the controls ( and control groups (p <0.001), but no significant difference was found between the no-DR and the control group (Table 1) . There were no significant differences between the groups in vitamin B12 (Table 1) .
Amongst patients from the diabetes groups, HbA1c levels were higher in DR than in controls (p <0.001), but there was no significant difference between the DR and no-DR groups (Table 1) . Triglycerides levels were higher (p <0.001) in diabetes patients (with and without DR) compared with the control subjects ( Table 1) . Plasma total chiolesterol was higher in the diabetes groups (DR and no-DR) compared with the controls (respectively; p <0.001 and 0.05; Table 1 ). Nevertheless, the levels of LDL-C were higher in the diabetes groups compared with the control group (p <0.001) ( Table 1) . No significant differences were found in the prevalence of hypertension, duration and smoking events among the groups with/without DR ( Table 1) .
tHCY levels were inversely related (p <0.05) to vitamin B12 and folic acid, when data of all the groups were considered (Table 2) . Interestingly, irrespective of groups, tHCY levels were associated with age and HbA1c levels (p <0.05) but not related to subjects duration of diabetes (Table 2) . Likewise, age was significantly (p <0.05) but inversely associated with vitamin B12 but not with folic acid and positively related with duration (Table 2) . tHCY, folate, vitamin B12, TG, Cholesterol, HDL-C, LDL-C were the only independent predictors of diabetic retinopathy in our study group (Table 3) . To examine the independent associations between the key risk factors and the presence of diabetic retinopathy, a logistic regression analysis combined by CochranMantel-Haenzel (CMH) pooling of odds ratio was performed with the significant variables in univariate analysis including age, vitamin B12, folate, TG, cholesterol and tHCY. The analysis showed that variables independently associated with diabetic retinopathy were >15 µM tHCY with an OR of 5.8 (95% confidence interval [CI], 1.6 to 25.4), folate with an OR of 2.0 (95% CI, 1.0 to 4.1), and TG with an OR of 2.4 (95% CI, 1.2 to 4.8) ( Table 4) .
Discussion
Currently, it is estimated that 45 million persons world-wide are blind, with an increase of 1-2 million each year (26) . On the other hand, only few literature reviews on this question have been published in Europe (3). DM is a major public health problem in around the world. T2DM affects approximately 24 million individuals in the United States (27) . Zaoui et al. (28) reported a prevalence of diabetes of 14.2% in a set of 7,656 subjects in urban and rural areas of Tlemcen (in Western Algeria), higher among men (20.4%) than women (10.7%). The prevalence of T2DM was 10.5% and of type 1 diabetes 3.7% (28) . Another study in our region (Sétif) showed that diabetes prevalence was 8.2%, without any difference according to sex nor urban (7.3%)/rural (9.7%) distribution (29) .
DR is a common ophthalmic complication that occurs primarily in the microvasculature of the retina and has been estimated to account for 5% of all cases of global blindness (30) , with estimates of 15%-17% in developed countries (5) . There are approximately 93 million people with DR worldwide (31) . Several hypotheses have been tested on the cause and pathogenesis of diabetic retinopathy (32) . The frequency and severity of DR are heterogeneous within and across ethnic groups (10) .
The present study did not show that a longer duration of DM in the group with retinopathy was a statistically significant risk factor for DR in comparison to the group without retinopathy. Longer duration of diabetes and poorer glycemic and blood pressure control are strongly associated with DR (31). However, Beulens et al. (33) reported that blood pressure lowering or intensive glucose control did not significantly reduce the incidence and progression of retinopathy in patients with T2DM. There are people who have a long duration of diabetes without DR and those who have severe DR despite relatively good glycemic control. In US adults with diabetes, race/ethnicity difference is thought to play a role in DR (10) . The present study showed that a longer duration of diabetes was not associated with DR, and this was true not only in univariate analysis but also in logistic regression analysis. There is no explanation for the variation in the severity of DR among diabetic patients with similar duration and control of the disease (20) . In addition, we believe that a longer follow-up period is needed to evaluate the long-term effects of duration on the progression of DR. To our knowledge, this is the first study focusing on the association and interaction of the plasma tHCY implicated in type T2DM with DR in Algerian population. There have been a number of studies concerning the relation between HCY and retinopathy. Patients with tHCY concentrations greater than 15 µM are considered to have HHCY and the condition is commonly associated with DM (15) .
It is a possible dose-response relation between the serum tHCY level and retinopathy, it is unknown whether this relation is graded or has a certain threshold. The results of the present study are in line with other studies (34) . Other studies showed no relation between tHCY concentrations and incidence of retinopathy of any grade but there was an association between increased tHCY and incidence of proliferative retinopathy (19) . It was shown that HHCY may be a risk factor for the development and progression of retinopathy in T2DM (21) . There are many studies have evaluated the association between tHCY and the incidence of DR, the results are varied and inconsistent (19, 22, 34) , in some studies this relation seems to be confounded by nephropathy (35) .
In the present study, the plasma levels of tHCY in the group with retinopathy were higher in comparison to those without not only in univariate analysis, but also in logistic regression analysis. The odds ratio between retinopathy and HHCY was 5.8 in our patients with diabetes, but there was no significant difference between the no-DR patients and the control group. These findings may in part explain the possible progression of DR in diabetic patients with higher tHCY levels compared to diabetic patients with lower tHCY levels who have no-DR, although the shorter diabetes duration (20) . The tHCY level was independently associated with DR according to multiple logistic regression analysis. Consequently, tHCY level may be a useful biomarker for increased risk of DR (32) .
Nutritional status, particularly micronutrients, may affect the risk of DR by influencing the biochemical mechanisms underlying DR (9) . Amongst the many determinants of tHCY, folic acid and vitamiB12 status is a major confounding factor (36) . However, very little is known about the extent to which B-vitamins status is associated with DR (9). The results of the present study show that lower levels of folic acid were observed in patients with DR. Therefore, lower vitamin B12 and folate status appears to be determining factor for increased tHCY in DR patients in this popu- lation. Further, vitamin B12 levels seem to be influenced by patient's age. Moreover, folic acid is 2-fold as likely in the DR group compared with the no-DR group, and in logistic regression analysis, these result also suggest that folic acid could be an independent risk factor for DR. From the present study, it is concluded that hypercholesterolemia, hypertriglyceridaemia and hyperlipoproteinemia are the main lipid abnormalities found in DR. It was shown that decreased HDL-C and elevated TG are independent risk factors for artherosclerosis, particularly in patients with DM (37) . Smoking was associated with an increased likelihood of having DR, as reported in other studies (38) . However, our results are in contrast with those and were in agreement with the observations of Shaya and Aljawadi (39) who found that cigarette smoking is not a risk factor for the development or progression of DR. Surprisingly, and unlike findings elsewhere (40) , the degree of hypertension control did not show any significant differences with DR in our study.
Independent variables
In conclusion, in the present study, which is the first be conducted in Algeria, we postulate that the HHCY might be associated with a higher risk of developing retinopathy among subjects with type 2DM relatively compared to several populations worldwide. Then, HHCY in diabetic patients may contribute to the severity of diabetic retinopathy. Unlike other risk factors, HHCY is readily reversible in most individuals with supplying folic acid and other vitamins. Our results will serve as a baseline to investigate on the possible causes of retinopathy in our population of subjects with type 2DM. 
